Company Overview - Jiangsu Hualv Biotechnology Group Co., Ltd. is located at 88 Lvdou Avenue, Siyang County, Jiangsu Province, established on June 8, 2010, and listed on April 12, 2021 [1] - The company's main business involves the research, industrial cultivation, and sales of edible mushrooms, with revenue composition being 70.73% from enoki mushrooms and 29.27% from king oyster mushrooms [1] Stock Performance - As of September 23, the stock price of Hualv Biotechnology decreased by 2.07%, trading at 13.70 CNY per share, with a total market capitalization of 1.664 billion CNY [1] - Year-to-date, the stock price has increased by 15.13%, but it has seen declines of 6.87% over the last five trading days, 12.07% over the last 20 days, and 8.30% over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on April 8 [1] Financial Performance - For the first half of 2025, Hualv Biotechnology reported a revenue of 499 million CNY, representing a year-on-year growth of 7.78%, while the net profit attributable to shareholders was -53.6947 million CNY, a decrease of 19.79% year-on-year [1] - Cumulative cash dividends since the A-share listing amount to 76.7904 million CNY, with 46.4484 million CNY distributed over the past three years [2] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 11.49% to 11,400, with an average of 8,162 circulating shares per person, a decrease of 10.31% [1] - Among the top ten circulating shareholders, CITIC Prudential Multi-Strategy Mixed Fund (LOF) A ranks as the third-largest shareholder, holding 2.0213 million shares, an increase of 1.2423 million shares from the previous period [2]
华绿生物跌2.07%，成交额368.50万元